mepivacaine (carbocaine) Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Dexivacaine is a local anesthetic drug that has minimal and non-significant side effects.   NCATS

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$0.0928 - $9.2260
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( mepivacaine (carbocaine), levonordefrin (Neo-Cobefrine) - other names: arestocaine hydrochloride w/ levonordefrin, isocaine hydrochloride w/ levonordefrin, polocaine w/ levonordefrin, scandonest l )

Alternative names

(+-)-1-methyl-2',6'-pipecoloxylidide | 1-methyl-2',6'-pipecoloxylidide | arestocaine hcl | carbocain | carbocaine | dl-mepivacaine | isocaine hcl | mepicaine | mepivacaina | mepivacaine | (+/-)-mepivacaine | mepivacaine hcl | mepivacaine hydrochloride | mepivacainum | mepivicaine | n-(2,6-dimethylphenyl)-1-methyl-2-piperidinecarboxamide | n-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide | polocaine | polocaine-mpf | scandicaine | scandonest | scandonest plain | tevacaine

Organizations (61)

Research & Development (51)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (10)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (50)

Approved Indications (1)


 

Anesthesia, Local (approved 1960)

Experimental Indications - Clinical Trial Phases 1-4 (50)


 

Acute Pain (Phase 1)

Ambulatory Surgical Procedures (Phase 4)

Analgesia (Phase 3)

Analgesics, Opioid (Phase 4)

Anesthesia (Phase 4)

Anesthesia, General (Phase 4)

Anesthesia, Local (Phase 4)

Anesthesia, Spinal (Phase 4)

Anesthetics, Local (Phase 3)

Ankle Injuries (Phase 4)

Arrhythmias, Cardiac (Phase 4)

Arthroplasty (Phase 4)

Arthroplasty, Replacement, Hip (Phase 4)

Arthroplasty, Replacement, Knee (Phase 4)

Arthroscopy (Phase 2)

Child Behavior (Phase 3)

Contraception (Phase 4)

Dental Caries (Phase 3)

Dental Pulp Diseases (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Early Ambulation (Phase 4)

Emergencies (Phase 3)

General Surgery (Phase 4)

Gingival Recession (Phase 4)

Healthy Volunteers (Phase 1)

Hypertension (Phase 4)

Intervertebral Disc Degeneration (Phase 1/Phase 2)

Intrauterine Devices (Phase 4)

Ischemic Stroke (Phase 2)

Leg Injuries (Phase 1)

Low Back Pain (Phase 1/Phase 2)

Morton Neuroma (Phase 4)

Nerve Block (Phase 4)

Orthopedic Procedures (Phase 4)

Osteoarthritis, Hip (Phase 4)

Osteoarthritis, Knee (Phase 4)

Pain (Phase 4)

Pain Management (Phase 4)

Pain, Postoperative (Phase 4)

Perineum (Phase 3)

Postoperative Nausea and Vomiting (Phase 4)

Prostatic Neoplasms (Phase 4)

Pulpitis (Phase 4)

Sciatic Neuropathy (Phase 4)

Spinal Diseases (Phase 1/Phase 2)

Stomatognathic Diseases (Phase 3)

Uterine Diseases (Phase 3)

Vaginal Discharge (Phase 3)

Varicose Veins (Phase 4)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 61
  • # of Trial Organizations: 51

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue